Entrectinib: a potent new TRK, ROS1, and ALK inhibitor

C. Rolfo, R. Ruiz, E. Giovannetti, I. Gil-Bazo, A. Russo, F. Passiglia, M. Giallombardo, M. Peeters, L. Raez

Research output: Contribution to journalArticleAcademicpeer-review

113 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1493-1500
JournalExpert opinion on investigational drugs
Issue number11
Publication statusPublished - 2015

Cite this